A comprehensive review of the loop diuretics: Should furosemide be first line?

Annals of Pharmacotherapy

Volumn 43, Issue 11, 2009, Pages 1836-1847

  Wargo, Kurt A ^a   Banta, William M ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Bumetanide; Ethacrynic acid; Furosemide; Loop diuretics; Torsemide

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; CANRENOATE POTASSIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETACRYNIC ACID; FUROSEMIDE; LOOP DIURETIC AGENT; RENIN; SPIRONOLACTONE; TORASEMIDE;

ALDOSTERONE BLOOD LEVEL; BODY WEIGHT; CENTRAL VENOUS PRESSURE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DIURESIS; DRUG COST; DRUG EFFECT; DRUG SAFETY; DYSPNEA; HEART EJECTION FRACTION; HEART FAILURE; HEART INNERVATION; HEART STROKE VOLUME; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; MEDLINE; MORTALITY; NATRIURESIS; NEPHROTIC SYNDROME; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; URINE VOLUME; WEIGHT REDUCTION;

FUROSEMIDE; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; LIVER CIRRHOSIS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 70449706438     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M177     Document Type: Review

References (38)

1. Top 200 prescription drugs of 2008. Pharmacy Times. www.pharmacytimes. com/issue/pharmacy/2009/2009-05/RxFocusTop200Drugs -0509 (accessed 2009 Jun 10).
2. Food and Drug Administration. Drugs@FDA: FDA approved drug products. www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm (accessed 2009 Mar 7).
3. Kim KE, Onesti G, Moyer JH, Swartz C. Ethacrynic acid and furosemide: diuretic and hemodynamic effects and clinical uses. Am J Cardiol 1971;27:407-415 DOI 10.1016/0002-9149(71)90438-3
4. Brater DC. Diuretic therapy. N Engl J Med 1998;339:387-395 DOI 10.1056/NEJM199808063390607
5. Huntsville Hospital acquisition cost www.novationco.com/marketplace- redirect.asp (accessed 2009 Jun 8).
6. Wal-Mart prescription drug coverage. www.walmart.com/catalog/catalog. gsp?cat=546834 (accessed 2009 Jun 8).
7. Drugstore.com pricing. www.drugstore.com/templates/browse/default. asp?catid=10663&trx=GFI-0-ROTABS&trxp1=10663&trxp4=60 (accessed 2009 Jun 8).
8. Olesen KH, Sigurd B, Steiness E, Leth A. Bumetanide, a new potent diuretic: a clinical evaluation in congestive heart failure. Acta Med Scand 1973;193:119-131
9. Asbury MJ, Gatenby PBB, O'Sullivan S, Bourke E. Bumetanide: potent new "loop" diuretic. Br Med J 1972;1:211-213
10. Blose JS, Adams KF, Patterson JH. Torsemide: a pyridine-sulfonylurea loop diuretic. Ann Pharmacother 1995;29:396-402.
11. Stewart JH, Edwards KDG. Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid. Br Med J 1965;2:1277-1281
12. Wang DJ, Gottlieb SS. Diuretics: still the mainstay of treatment. Crit Care Med 2008;36(1-suppl):S89-94.
13. Brater DC. Clinical pharmacology of loop diuretics. Drugs 1991;41(suppl 3):14-22. DOI 10.2165/00003495-199100413-00004
14. Knauf H, Mutschler E. Clinical pharmacokinetics and pharmacodynamics of torsemide. Clin Pharmacokinet 1998;34:1-24. DOI 10.2165/00003088-199834010-00001
15. Murdoch WR, Auld WH. Bumetanide - acute and long term studies of a new high potency diuretic. Postgrad Med J 1975;51:10-14 DOI 10.1136/pgmj.51.591.10
16. Henning R, Lundvall O. Evaluation in man of bumetanide, a new diuretic agent. Eur J Clin Pharmacol 1973;6:224-227 DOI 10.1007/BF00644736
17. Stason WB, Cannon PJ, Heinemann HO, Laragh JH. Furosemide: a clinical evaluation of its diuretic action. Circulation 1966;34:910-920
18. Fowler SF, Murray KM. Torsemide: a new loop diuretic. Am J Health Syst Pharm 1995;52:1771-1780
19. Uchida T, Yamanaga K, Nishikawa M, Ohtaki Y, Kido H, Watanabe M. Anti-aldosteronergic effects of torasemide. Eur J Pharmacol 1991;205: 145-150
20. Uchida T, Yamanaga K, Kido H, Ohtaki Y, Watanabe M. Diuretic and vasodilating actions of torasemide. Cardiology 1994;84(suppl 2):14-17
21. Kasama S, Toyama T, Hatori T, et al. Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. Heart 2006;92:1434-1440 (Pubitemid 44578836)
22. Yamato M, Sasaki T, Honda K, et al. Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure. Circ J 2003;67:384-90. Erratum: Circ J 2003;67:565; Circ J 2003;67:649.
23. López B, Querejeta R, González A, Sánchez E, Larman M, Díez J. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol 2004;43:2028-2035 (Pubitemid 38686797)
24. López B, González A, Beaumont J, Querejeta R, Larman M, Díez J. Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure. J Am Coll Cardiol 2007;50:859-867 (Pubitemid 47268745)
25. Murray MD, Deer MM, Ferguson JA, et al. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 2001;111:513-520 DOI 10.1016/S0002-9343(01)00903-2
26. Cosin J, Diez J, on behalf of the TORIC investigators. Torsemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail 2002; 4:507-513 DOI 10.1016/S1388-9842(02)00122-8
27. Müller K, Gamba G, Jaquet F, Hess B. Torsemide vs furosemide in primary care patients with chronic heart failure NYHA II to IV - efficacy and quality of life. Eur J Heart Fail 2003;5:793-801. DOI 10.1016/S1388-9842(03) 00150-8 (Pubitemid 38198067)
28. Laffi G, Marra F, Buzzelli G, et al. Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. Hepatology 1991;13:1101-1105
29. Gerbes AL, Bertheau-Reitha U, Falkner C, Jüngst D, Paumgartner G. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial. J Hepatol 1993;17:353-358 (Pubitemid 23134933)
30. Fiaccadori F, Pedretti G, Pasetti G, Pizzaferri P, Elia G. Torsemide versus furosemide in cirrhosis: a long-term double-blind, randomized clinical study. Clin Investig 1993;71:579-584 (Pubitemid 23200945)
31. Abecasis R, Guevera M, Miguez C, Cobas S, Terg R. Long-term efficacy of torsemide compared to frusemide in cirrhotic patients with ascites. Scand J Gastroenterol 2001;3:309-313 (Pubitemid 32234582)
32. von Dossow V, Spies C, Schenk H, Schlesinger S, von Heymann C. Secondary pulmonary hypertension: haemodynamic effects of torasemide versus furosemide. Clin Drug Investig 2008;28:17-26. (Pubitemid 350274397)
33. Vasavada N, Saha C, Agarwal R. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease. Kidney Int 2003; 64:632-640 (Pubitemid 36871936)
34. Vargas Hein O, Staegemann M, Wagner D, et al. Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients. Ren Fail 2005;27:385-392 (Pubitemid 40993686)
35. Whelton A. Long-term bumetanide treatment of renal edema. Comparison with furosemide. J Clin Pharmacol 1981;21:591-598 (Pubitemid 12166944)
36. Ramsay F, Crawford RJ, Allman S, Bailey R, Martin A. An open comparative study of two diuretic combinations, frusemide/amiloride ('Frumil') and bumetanide/potassium chloride ('Burinex'K), in the treatment of congestive cardiac failure in hospital out-patients. Curr Med Res Opin 1988;10:682-689
37. Stroupe KT, Forthofer MM, Brater DC, Murray MD. Healthcare costs of patients with heart failure treated with torasemide or furosemide. Pharmacoeconomics 2000;17:429-440 DOI 10.2165/00019053-200017050-00002 (Pubitemid 30398802)
38. Noe LL, Vreeland MG, Pezzella SM, Trotter JP. A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure. Clin Ther 1999;21:854-866 (Pubitemid 29291443)